Heart drug for blacks priced according to patient's income

07/8/2005 | NYTimes.com

NitroMed has provoked controversy with a pricing plan for its recently approved heart drug for blacks. The basic price per pill is higher than expected, analysts say, but the company also is offering steep discounts for poor or uninsured patients, meaning the drug is priced according to patients' wealth.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN